These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37403840)

  • 1. Phosphoproteome analysis of cerebrospinal fluid extracellular vesicles in primary central nervous system lymphoma.
    Deng Y; Li Q; Sun J; Ma L; Ding Y; Cai Y; Iliuk A; Chen B; Xie Z; Tao WA
    Analyst; 2023 Jul; 148(15):3594-3602. PubMed ID: 37403840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling Phosphoproteome Landscape in Circulating Extracellular Vesicles from Microliters of Biofluids through Functionally Tunable Paramagnetic Separation.
    Sun J; Li Q; Ding Y; Wei D; Hadisurya M; Luo Z; Gu Z; Chen B; Tao WA
    Angew Chem Int Ed Engl; 2023 Jul; 62(29):e202305668. PubMed ID: 37216424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study.
    Li J; Tang X; Luo X; Liu L; Li D; Yang L
    Ann Hematol; 2023 Aug; 102(8):2153-2163. PubMed ID: 37289220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic role and dynamic changes in cerebrospinal fluid neopterin during treatment of patients with primary central nervous system lymphoma.
    Geng M; Xiao H; Liu J; Song Y; Fu P; Cheng X; Zhang J; Wang G
    Cancer Med; 2018 Aug; 7(8):3889-3898. PubMed ID: 29982995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study.
    Ferreri AJM; Calimeri T; Lopedote P; Francaviglia I; Daverio R; Iacona C; Belloni C; Steffanoni S; Gulino A; Anghileri E; Diffidenti A; Finardi A; Gagliardi F; Anzalone N; Nonis A; Furlan R; De Lorenzo D; Terreni MR; Martinelli V; Sassone M; Foppoli M; Angelillo P; Guggiari E; Falini A; Mortini P; Filippi M; Tarantino V; Eoli M; Ciceri F; Doglioni C; Tripodo C; Locatelli M; Cangi MG; Ponzoni M
    Br J Haematol; 2021 May; 193(3):497-505. PubMed ID: 33620087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly Efficient Phosphoproteome Capture and Analysis from Urinary Extracellular Vesicles.
    Wu X; Li L; Iliuk A; Tao WA
    J Proteome Res; 2018 Sep; 17(9):3308-3316. PubMed ID: 30080416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma-Derived Extracellular Vesicle Phosphoproteomics through Chemical Affinity Purification.
    Iliuk A; Wu X; Li L; Sun J; Hadisurya M; Boris RS; Tao WA
    J Proteome Res; 2020 Jul; 19(7):2563-2574. PubMed ID: 32396726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary diffuse large B-cell lymphoma of the central nervous system identified with CSF biomarkers.
    Loser V; Segot A; de Leval L; Bisig B; Brouland JP; Hewer E; Barcena C; Hottinger AF; Pot C
    BMC Neurol; 2024 Jul; 24(1):250. PubMed ID: 39039441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted multiplex validation of CSF proteomic biomarkers: implications for differentiation of PCNSL from tumor-free controls and other brain tumors.
    Ma J; Lin Z; Zhang Y; Ding Y; Tang Q; Qian Y; Jin B; Luo RY; Liao WL; Thyparambil S; Han Z; Chou CJ; Schilling J; Li Q; Zhang M; Lin Y; Ma Y; Sylvester KG; Nagpal S; McElhinney DB; Ling XB; Chen B
    Front Immunol; 2024; 15():1343109. PubMed ID: 39144147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of central nervous system lymphoma via cerebrospinal fluid cytology: a case report.
    Zhao H; Ma M; Zhang L; Zheng G; Lv H; Liu J; Li X; Song B; Zhang G
    BMC Neurol; 2019 May; 19(1):90. PubMed ID: 31064334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.
    Viaccoz A; Ducray F; Tholance Y; Barcelos GK; Thomas-Maisonneuve L; Ghesquières H; Meyronet D; Quadrio I; Cartalat-Carel S; Louis-Tisserand G; Jouanneau E; Guyotat J; Honnorat J; Perret-Liaudet A
    Neuro Oncol; 2015 Nov; 17(11):1497-503. PubMed ID: 26014047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
    Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
    J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for primary central nervous system lymphoma.
    Baraniskin A; Zaslavska E; Nöpel-Dünnebacke S; Ahle G; Seidel S; Schlegel U; Schmiegel W; Hahn S; Schroers R
    Neuro Oncol; 2016 Mar; 18(3):361-7. PubMed ID: 26250566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma.
    De Luca A; Antinori A; Cingolani A; Larocca LM; Linzalone A; Ammassari A; Scerrati M; Roselli R; Tamburrini E; Ortona L
    Br J Haematol; 1995 Aug; 90(4):844-9. PubMed ID: 7669663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-30c as a novel diagnostic biomarker for primary and secondary B-cell lymphoma of the CNS.
    Baraniskin A; Chomiak M; Ahle G; Gress T; Buchholz M; Turewicz M; Eisenacher M; Margold M; Schlegel U; Schmiegel W; Hahn S; Schroers R
    J Neurooncol; 2018 May; 137(3):463-468. PubMed ID: 29327175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors.
    Downs BM; Ding W; Cope LM; Umbricht CB; Li W; He H; Ke X; Holdhoff M; Bettegowda C; Tao W; Sukumar S
    Clin Epigenetics; 2021 May; 13(1):104. PubMed ID: 33952317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma.
    Song Y; Zhang W; Zhang L; Wu W; Zhang Y; Han X; Yang C; Zhang L; Zhou D
    Sci Rep; 2016 Dec; 6():38671. PubMed ID: 27924864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of CSF soluble CD27 for primary central nervous system lymphoma in immunocompetent patients.
    Murase S; Saio M; Andoh H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Takami T
    Neurol Res; 2000 Jul; 22(5):434-42. PubMed ID: 10935213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and Phosphoproteomic Analysis of Plasma-Derived Extracellular Vesicles.
    Iliuk AB
    Methods Mol Biol; 2022; 2504():147-156. PubMed ID: 35467285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Logistic regression modeling of cytokines for cerebrospinal fluid evaluation in primary central nervous system lymphoma.
    Wang D; Wu Y; Ma J; Xu Z; Tao H; Guan Y; Wang J; Chen K; Chen B; Xie J; Jiang H; Guan M
    Clin Chim Acta; 2024 Aug; 562():119879. PubMed ID: 39029646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.